Skip to content

Gary A Lyons, Director at Travere Therapeutics, sold TVTX on Aug 17, 2026

Data as of Oct 16

▼ SELL$165K2,600 shares at $63.50Gary A Lyons DirectorTVTX Travere Therapeutics, Inc.
Watch TVTX
Traded
Aug 17, 2026
Disclosed
Aug 19, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Gary A Lyons, Director at Travere Therapeutics, sold TVTX on Aug 17, 2026TRADEDDISCLOSED
TVTXSimilar stocks (XLV — its sector index fund), rebased to TVTX's price on the disclosure day
TVTX since disclosure
−24.8%
after the sale
Similar stocks (XLV) since disclosure
+0.6%
XLV — its sector index fund

Change in closing price from Aug 19, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$259Kdisclosed Aug 19 · filed 1 day after the trade
  2. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$57.5Kdisclosed Aug 19 · filed 1 day after the trade
  3. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$119Kdisclosed Aug 19 · filed 2 days after the trade
  4. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$32.1Kdisclosed Aug 19 · filed 2 days after the trade

See every trade on TVTX →